24.03

2.71% -0.67

Fortrea Holdings Inc (FTRE)

Overview News Price History Option Chain Financials Why FTRE Down? Discussions Forecast

Fortrea Holdings Inc stock is currently priced at $24.03, with a 24-hour trading volume of 115.52K. It has seen a -2.71% decreased in the last 24 hours and a -16.68% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $24.64 pivot point. If it approaches the $23.86 support level, significant changes may occur.

Previous Close:

$24.70

Open:

$24.53

24h Volume:

115.52K

Market Cap:

$2.21B

Revenue:

$3.01B

Net Income/Loss:

$-121.80M

P/E Ratio:

18.36

EPS:

1.3088

Net Cash Flow:

$110.40M

1W Performance:

-9.35%

1M Performance:

-16.68%

6M Performance:

-26.56%

1Y Performance:

+0.00%

1D Range:

$24.01

$24.53

52W Range:

$24.01

$41.02

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name

Fortrea Holdings Inc

Sector

Healthcare (1208)

Industry

Biotechnology (692)

Phone

877-495-0816

Address

8 Moore Drive, Durham

Employee

19,000

Twitter

Next Earnings Date

Latest SEC Filings

FTRE's Discussions on Twitter

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-22-24	Initiated	Robert W. Baird	Neutral
Mar-06-24	Initiated	Deutsche Bank	Hold
Jan-05-24	Initiated	William Blair	Mkt Perform
Jan-04-24	Initiated	Jefferies	Buy
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Dec-01-23	Upgrade	Evercore ISI	In-line → Outperform
Nov-14-23	Upgrade	Barclays	Equal Weight → Overweight
Oct-19-23	Initiated	Citigroup	Neutral
Sep-14-23	Initiated	Evercore ISI	In-line
Aug-16-23	Initiated	Barclays	Equal Weight
Aug-07-23	Initiated	BofA Securities	Underperform

View All

Fortrea Holdings Inc Stock (FTRE) Latest News

Closing Figures Unveiled: Fortrea Holdings Inc (FTRE) Drop -0.52, Closes at 24.70 – DWinneX - The Dwinnex

The Dwinnex

Gates Capital Management Inc. Makes New $67.86 Million Investment in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

MarketBeat

Fortrea (FTRE) and Its Rivals Financial Review - Defense World

Defense World

James S. Hanson Purchases 2,000 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) Stock - MarketBeat

MarketBeat

Fortrea Holdings general counsel buys $50600 in company stock - Investing.com India

Investing.com India

Fortrea Holdings Inc (FTRE) Performance and Fundamentals Dashboard tells a completely different story – Sete News - SETE News

SETE News

Fortrea Holdings Inc Stock (FTRE) Financials Data

Fortrea Holdings Inc (FTRE) Revenue 2024

FTRE reported a revenue (TTM) of $3.01 billion for the quarter ending March 31, 2024, a -0.14% decline year-over-year.

Fortrea Holdings Inc (FTRE) Net Income 2024

FTRE net income (TTM) was -$121.80 million for the quarter ending March 31, 2024, a -170.45% decrease year-over-year.

Fortrea Holdings Inc (FTRE) Cash Flow 2024

FTRE recorded a free cash flow (TTM) of $110.40 million for the quarter ending March 31, 2024, a +27.04% increase year-over-year.

Fortrea Holdings Inc (FTRE) Earnings per Share 2024

FTRE earnings per share (TTM) was -$1.37 for the quarter ending March 31, 2024, a -170.07% decline year-over-year.

Fortrea Holdings Inc Stock (FTRE) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Hanson James S.	General Counsel	Jun 03 '24	Option Exercise	0.00	7,706	0	7,706
Warren Amanda M.	Chief Accounting Officer	Jun 03 '24	Option Exercise	0.00	3,842	0	6,411
Mcconnell Jill G.	Chief Financial Officer	Jun 03 '24	Option Exercise	0.00	11,000	0	31,717
Morais Mark A.	Chief Operating Officer	Jun 03 '24	Option Exercise	0.00	11,000	0	29,406
Pike Thomas	Chief Executive Officer	May 29 '24	Buy	24.81	10,000	248,066	57,827
Larson Betty D	Former Director	Mar 30 '24	Option Exercise	0.00	6,354	0	6,354
Mcconnell Jill G.	Chief Financial Officer	Mar 04 '24	Option Exercise	0.00	20,776	0	26,815
Morais Mark A.	Chief Operating Officer	Mar 04 '24	Option Exercise	0.00	15,368	0	22,856
Warren Amanda M.	Chief Accounting Officer	Feb 11 '24	Option Exercise	0.00	1,068	0	2,935
Mcconnell Jill G.	Chief Financial Officer	Feb 11 '24	Option Exercise	0.00	1,544	0	6,486

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.